Revalor-100 10 mg Implant is a Health Canada–registered veterinary drug (DIN 02429136) held by Intervet Canada Corp, containing Estradiol. Health Canada lists its status as Marketed (status date 22 Jan 2018). Nexara Health has matched 882 registrations of Estradiol across 33 other regulated markets, 1 of them in the same strength and dosage form.

Health Canada registration

Estradiol registered in other markets

882 registrations of the same molecule in 33 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Estradiol worldwide →

Regulator price references for Estradiol

Published list or reimbursement prices for Estradiol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Revalor-100 (DIN 02429136) marketed in Canada?

Yes. Health Canada lists DIN 02429136 as Marketed as of 22 Jan 2018.

Who holds the Canadian licence for this product?

Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.

Is Estradiol registered outside Canada?

Yes — Nexara Health has matched 882 registrations in 33 other markets, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02429136, status date 2018-01-22; national medicine registries: BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NPRA, PAMI, PBS, SUKL DLP; price sources: CMED, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02429136, status date 2018-01-22; national medicine registries: BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NPRA, PAMI, PBS, SUKL DLP; price sources: CMED, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, PBS.

Health Canada Drug Product Database (DPD), DIN 02429136, status date 2018-01-22; national medicine registries: BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NPRA, PAMI, PBS, SUKL DLP; price sources: CMED, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.